ClinConnect ClinConnect Logo
Search / Trial NCT04054440

Outpatient Office Based Endovascular Procedures

Launched by METHODIST HEALTH SYSTEM · Aug 12, 2019

Trial Information

Current as of November 07, 2025

Enrolling by invitation

Keywords

Office Based Angiosuite

ClinConnect Summary

This is an observational study that looks at real-world outcomes of endovascular procedures (minimally invasive work inside the blood vessels) done in an office-based setting called an angiosuite. Researchers want to learn about safety and short-term outcomes, such as where patients go after the procedure (home, hospital, ICU, or emergency department) and any complications within 24 hours. The goal is to gather information that could guide future research and, later, help compare office-based care with hospital-based care.

Who might be eligible? Adults 18 years and older who have conditions like peripheral arterial disease, chronic venous insufficiency, dialysis access problems, malfunctions of arteriovenous fistulas, varicose veins, vertebrobasilar insufficiency, or thoracic outlet syndrome, and who have procedures done as outpatients in an office-based angiosuite by board-certified vascular surgeons in California or Texas. The study plans to enroll about 300 participants and is currently enrolling by invitation; results have not yet been published. The listed site is Methodist Dallas Medical Center in Dallas, Texas, sponsored by Methodist Health System, with Dr. Sam S Ahn, MD as the principal investigator.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years.
  • Diagnosis of peripheral arterial disease (PAD), chronic venous insufficiency, dialysis access and malfunctioning arteriovenous fistulas, varicose veins, vertebrobasilar insufficiency, and thoracic outlet syndrome.
  • Procedures performed as an outpatient in an office based angiosuite.
  • Exclusion Criteria:
  • Age ≤ 18 years

About Methodist Health System

Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Trial Officials

Sam S Ahn, MD

Principal Investigator

DFW Vascuclar

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials